Ally Bridge Group »

Cg Oncology shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 320k 43.90

More positions owned by Ally Bridge Group

Blueprint Medicines (BPMC)
Soleno Therapeutics (SLNO)
Cg Oncology (CGON)
Xenon Pharmaceuticals (XENE)
Verona Pharma Sponsored Ads (VRNA)
Merus N V (MRUS)
Praxis Precision Medicines I (PRAX)
Mind Medicine Mindmed Com New (MNMD)
Avadel Pharmaceuticals Sponsored Adr
Geron Corporation (GERN)
Jasper Therapeutics Com New (JSPR)
Kura Oncology (KURA)
Insmed Com Par $.01 (INSM)
Dianthus Therapeutics (DNTH)
Olema Pharmaceuticals (OLMA)

View all positions for Ally Bridge Group

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
BlackRock
Braidwell
Vanguard Group
BlackRock
Avidity Partners Management
Henderson Group
RA Capital Management
Franklin Resources
Geode Capital Management
Alliancebernstein
BVF
State Street Corporation
Cormorant Asset Management

View all funds holding Cg Oncology